Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of SPT-07A injection in acute ischemic stroke
ChiCTR2100054042Phase 3Not yet recruiting
- Sponsor
- Union Hospital
- Start
- Jan 2022
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of d-borneol in ischemic stroke (2 arms), sponsored by Union Hospital. Primary endpoint: Proportion of participants with modified Rankin Scale score 0 to 1. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
d-borneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR2100054042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054042.